Sara Duffett
University of Leeds
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sara Duffett.
Alimentary Pharmacology & Therapeutics | 2002
James Mason; A. T. R. Axon; David Forman; Sara Duffett; Michael Drummond; Will Crocombe; Richard G. Feltbower; Su Mason; Julia Brown; Paul Moayyedi
Economic models have suggested that population Helicobacter pylori screening and treatment may be a cost‐effective method of reducing mortality from gastric cancer. These models are conservative as they do not consider that the programme may reduce health service peptic ulcer and other dyspepsia costs. We have evaluated the economic impact of population H. pylori screening and treatment over 2 years in a randomized controlled trial and have incorporated the results into an economic model exploring the impact of H. pylori eradication on peptic ulcer disease and gastric cancer.
European Journal of Gastroenterology & Hepatology | 2002
Paul Moayyedi; Mark Wardman; Jeremy Toner; Mandy Ryan; Sara Duffett
Objective The Department of Health states that patients with suspected cancer should be seen within 2 weeks, and the Patients’ Charter suggests that patients should not wait for more than 30 min in outpatients. Decisions such as these are often made with little assessment of patient preferences. We have elicited patient preferences for the optimal use of time in the outpatient clinic. Design Questionnaire survey eliciting preference between different clinic scenarios evaluated using discrete choice conjoint analysis. Setting and participants Patients attending a teaching hospital gastroenterology outpatient clinic. Main outcome measures The relative importance of time spent on the waiting list, time waiting in the clinic, time spent with the specialist, and time waiting for investigation was assessed using a logit model. Results Patients placed a similar value on waiting for investigation and time spent on the waiting list. A clinic that had a 2-month waiting list but offered immediate investigations would therefore be more popular than a clinic that had a 2-week waiting list but whose investigations were deferred for 3 months. Patients would be prepared to spend an extra 30 min in the waiting room if they spent 1 month less on the waiting list or waiting for investigation. Time spent with a specialist is valued, and patients would be prepared to spend an extra 3 min waiting in the clinic for every extra minute spent with the doctor. Conclusions The present Department of Health recommendations and the Patients’ Charter are too simplistic and do not take into account patient preferences.
International Journal of Epidemiology | 2002
Paul Moayyedi; A. T. R. Axon; Richard G. Feltbower; Sara Duffett; Will Crocombe; David Braunholtz; Id Gerald Richards; Anthony Dowell; David Forman
European Journal of Epidemiology | 2005
Paul Moayyedi; David Forman; Sara Duffett; Su Mason; Julia Brown; Will Crocombe; Richard G. Feltbower; A. T. R. Axon
International Journal of Technology Assessment in Health Care | 1999
James Mason; Paul Moayyedi; Philip Young; Sara Duffett; Will Crocombe; Michael Drummond; A. T. R. Axon
International Journal of Technology Assessment in Health Care | 1999
James Mason; Paul Moayyedi; Philip Young; Sara Duffett; Will Crocombe; Michael Drummond; A. T. R. Axon
Gastroenterology | 2001
Paul Moayyedi; Sara Duffett; Shelly Soo; A. T. R. Axon
Gastroenterology | 2000
Paul Moayyedi; Richard G. Feltbower; Sara Duffett; Will Crocombe; David Forman; A. T. R. Axon
International Journal of Technology Assessment in Health Care | 1999
James Mason; Paul Moayyedi; Philip Young; Sara Duffett; Will Crocombe; Michael Drummond; A. T. R. Axon
Gastroenterology | 2000
Paul Moayyedi; Mark Wardman; Jeremy Toner; Sara Duffett; A. T. R. Axon